Nephrotic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition:   Nephrotic Syndrome Interventions:   Drug: Dapagliflozin and Standard therapy (ACEI or ARB).;   Drug: Standard Therapy (ACEI or ARB). Sponsor:   Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials